Stocktoria
Solid Biosciences Inc. SLDB
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2018-01-26
Solid Biosciences Inc. financials (annual)
Bars are annual figures from 2017 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | $8.1M | $13.6M | $0 | $0 | $0 | $0 |
| R&D expense | $140.3M | $96.4M | $76.6M | $78.4M | $58.7M | $64.9M | $94.7M | $58.0M | $39.9M |
| Operating income | -$179.2M | -$129.7M | -$104.3M | -$106.5M | -$72.3M | -$88.4M | -$119.3M | -$75.7M | -$54.9M |
| Income tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | — |
| Net income | — | — | — | — | — | — | -$117.2M | -$74.8M | -$52.1M |
| EPS (diluted) | $-1.99 | $-3.06 | $-4.83 | $-10.10 | $-10.14 | $-25.50 | — | — | — |
| Operating cash flow | -$156.3M | -$100.0M | -$94.2M | -$98.0M | -$77.8M | -$56.6M | -$92.7M | -$70.2M | -$43.2M |
| Free cash flow | -$157.4M | -$100.7M | -$95.7M | -$101.0M | -$79.0M | -$57.5M | -$97.1M | -$78.0M | -$45.5M |
| Cash & equivalents | $59.9M | $80.2M | $74.0M | $155.4M | $119.1M | $154.7M | $76.0M | $86.4M | $52.1M |
| Total assets | $232.5M | $188.7M | $164.9M | $260.3M | $232.4M | $171.2M | $103.5M | $139.6M | $76.2M |
| Total liabilities | $52.5M | $51.4M | $38.5M | $48.6M | $24.2M | $39.1M | $23.4M | $14.4M | $11.3M |
| Shareholders' equity | $180.0M | $137.2M | $126.5M | $211.7M | $208.2M | $132.1M | $80.0M | $125.2M | -$59.3M |
Growth · year-over-year
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | — | — | — | -40.6% | — | — | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.